Clark Estates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Clark Estates's BIIB Position: Q3 2026 in Review
Clark Estates sold out of Biogen (BIIB) in Q3 2026, closing a stake of 15,300 shares — an estimated $3.31M sold.
Clark Estates first reported a position in BIIB in Q2 2018 and held it in 22 quarters. The position peaked at $5.48M in Q1 2021. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Clark Estates reported no remaining Biogen position as of Q3 2026 after selling out during the quarter.
- Clark Estates sold 15,300 Biogen shares in Q3 2026, an estimated $3.31M.
- Clark Estates first reported a position in Biogen in Q2 2018 and held it in 22 quarters.
- Clark Estates's Biogen position peaked at $5.48M in Q1 2021.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.